Ruxolitinib tablets used to treat myelofibrosis, polycythemia vera and graft-versus-host disease
Contains ruxolitinib 5mg, a JAK1/JAK2 inhibitor that reduces overactive blood cell signaling, used to treat myelofibrosis, polycythemia vera and steroid-refractory graft-versus-host disease. 56 Tablets.
Attributes
Product Content
How to Use:
• Take exactly as prescribed by your doctor, usually twice daily.
• Swallow whole with water, with or without food.
• Regular blood counts are needed; do not stop suddenly without medical advice.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.